Procainamide
- Generic Name
- Procainamide
- Brand Names
- Procan
- Drug Type
- Small Molecule
- Chemical Formula
- C13H21N3O
- CAS Number
- 51-06-9
- Unique Ingredient Identifier
- L39WTC366D
- Background
A derivative of procaine with less CNS action.
- Indication
For the treatment of life-threatening ventricular arrhythmias.
- Associated Conditions
- Supraventricular Arrhythmias, Ventricular Tachycardia (VT), Life-threatening ventricular arrhythmias, Pre-excited atrial fibrillation
- Associated Therapies
- -
RAFF4 Trial: Vernakalant vs. Procainamide for Acute Atrial Fibrillation in the Emergency Department
- First Posted Date
- 2020-07-24
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Ottawa Hospital Research Institute
- Target Recruit Count
- 340
- Registration Number
- NCT04485195
- Locations
- 🇨🇦
Kingston Health Sciences Centre, Kingston, Ontario, Canada
🇨🇦St. Michaels, Toronto, Ontario, Canada
🇨🇦University of Alberta Hospital, Edmonton, Alberta, Canada
Prevention of Post-Operative Cardiac Arrhythmias
- First Posted Date
- 2020-01-21
- Last Posted Date
- 2022-03-15
- Lead Sponsor
- Jeffrey Moak
- Target Recruit Count
- 870
- Registration Number
- NCT04234906
Acute Mechanical Response to Anti-arrhythmic Drug Therapy
- First Posted Date
- 2015-10-14
- Last Posted Date
- 2018-06-28
- Lead Sponsor
- Evan Adelstein, MD
- Registration Number
- NCT02575534
- Locations
- 🇺🇸
Evan Adelstein, Pittsburgh, Pennsylvania, United States
ST-segment Elevation as an AF Endophenotype
- First Posted Date
- 2010-09-20
- Last Posted Date
- 2018-05-02
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 161
- Registration Number
- NCT01205529
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-06-20
- Last Posted Date
- 2010-12-15
- Lead Sponsor
- Hospital Clinic of Barcelona
- Target Recruit Count
- 123
- Registration Number
- NCT00702117
- Locations
- 🇪🇸
Hospital Puerta de Hierro, Madrid, Spain
🇪🇸Hospital Donostia, Donostia, Guipuzcoa, Spain
🇪🇸Hospital La Fe, Valencia, Spain
Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
Phase 3
Completed
- Conditions
Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)
Phase 3
Completed
- Conditions
- First Posted Date
- 1999-10-28
- Last Posted Date
- 2013-07-29
- Lead Sponsor
- University of Washington
- Registration Number
- NCT00000464
Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)
- First Posted Date
- 1999-10-28
- Last Posted Date
- 2016-01-21
- Lead Sponsor
- University of Utah
- Registration Number
- NCT00000518
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath